Literature DB >> 1873233

Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor.

M L Schmidt1, H E Smith, S Gamerman, D DiMichele, S Glazer, J P Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1873233     DOI： 10.1111/j.1365-2141.1991.tb04468.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.

Authors:  P Mizon; J Goudemand; B Jude; A Marey
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 2.  Pharmacological approaches to reduce perioperative transfusion requirements in the aged.

Authors:  T Tasaki; H Ohto; R Motoki
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.